Until now, it was known that ticks primarily transmit two pathogens to humans in Switzerland: the bacterium Borrelia burgdorferi which causes borreliosis and the early-summer-meningoencephalitis virus, which can cause cerebral inflammation. Now, microbiologists from the University of Zurich confirm the existence of another tick disease in Switzerland neoehrlichiosis.
The pathogenic bacteria Candidatus Neoehrlichia mikurensis was first discovered in ticks and rodents in Europe and Asia in 1999. In 2010, Guido Bloemberg, head of molecular diagnostics at the Institute of Medical Microbiology, and colleagues from Sweden and Germany, diagnosed the world's first infections in humans and dubbed the disease "neoehrlichiosis," by detection of the bacterium in the patients' blood. Two more cases were identified at the University of Zurich's Institute of Medical Microbiology in October 2011 and January 2012. So far, a total of eight patients have been described in Europe, three of whom come from the Zurich area. They suffered from relapsing fevers of up to 40 degrees, weight loss and general malaise.
Bloemberg's team studied around 2,000 ticks from the neighborhood of the three Swiss patients, who often spent time in forests and fields. The result: A large number of ticks in the Zurich area  5 percent to 10 percent carry Candidatus Neoehrlichia mikurensis.
"Our study shows that the greater Zurich region is a risk area for neoehrlichiosis, especially for immunocompromised people," explains Florian Maurer from the University of Zurich's Institute of Medical Microbiology.
Almost all the patients in Europe to date have had a weakened immune system. However, people with a healthy immune system recently contracted neoehrlichiosis from a tick bite in China, too.
"Because the bacteria that cause neoehrlichiosis couldn't be bred in the lab until now and thus no rapid tests were available, many infections might have remained undetected," says Bloemberg.
However, help is now at hand with the new DNA test the researchers have developed: It can detect an infection definitively within one working day and also be used for larger test series.
The Swiss patients could be cured fully with a course of antibiotics. Within only a few weeks of beginning the treatment, the microorganism responsible could no longer be detected in their blood.
"How well the bacterium is transmitted to humans via a bite from an infected tick, however, still needs to be researched," Bloemberg adds.
Reference: Maurer F, Keller P, et al.  Close geographic association of human neoehrlichiosis and tick populations carrying Candidatus Neoehrlichia mikurensis in Eastern Switzerland. Journal of Clinical Microbiology, 31 October, 2012. DOI: 10.1128/JCM.01955-12
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.